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It has been a pleasure and an honor to serve as the 29th
President of the New England Society for Vascular Surgery,
the oldest regional vascular society in the United States. I
would like to share with you some thoughts I have about
the current environment of carotid artery surgery. There
are a number of innovative changes currently developing in
our specialty, which makes this a very exciting time. What
role some of the many new technologies will have in future
vascular practice only time will tell. I am not here to praise
or to condemn carotid artery stenting. Currently there are
eight trials or registries in various states of activity trying to
determine what exact role carotid artery stenting will play in
the treatment of patients with extracranial carotid artery
disease. In my opinion, there are currently no level I data
available to help us make a clinical decision about using
these new modalities for our patients at this time. I am
concerned that we are losing sight of what we currently
have available for the treatment of patients with carotid
artery disease. Some have suggested that carotid endarter-
ectomy results are not as good as have been suggested by
the results of national trials. I would like to take this
opportunity to reflect on some of the issues relevant to
these suggestions.
I apologize for the somewhat negative tone of my title,
but I do believe that at this time carotid endarterectomy is
under attack again, and I hope to help set the record
straight.
The report by Eastcott et al1 in 1954 represents where
it all began and when the operation began to gain popular-
ity. Although Carrea et al2 did perform carotid surgery,
which was an external carotid to internal carotid anastomo-
sis, they did not report this case until 1955. Strully et al3
reported in 1953 an attempt at thrombectomy of the
internal carotid artery, but retrograde flow could not be
established, and the artery was ligated. DeBakey4 did a
carotid endarterectomy, using the technique we now know,
in 1953, but this was not reported until 1975. I believe that
the operation performed at St Mary’s Hospital in 1954 by
Eastcott and colleagues and published in The Lancet in
1954 opened the door to our thinking that correction of
extracranial carotid artery disease could improve neurologic
symptoms. Prior to the operation the patient, a 66-year-old
woman, had 33 attacks of transient cerebral ischemia. After
surgery the symptoms were gone. For many years after that
operation there were arguments on both sides of the fence
for and against the operation as being successful in the
treatment of patients with neurologic symptoms. Even
more heatedly argued was the role of carotid endarterec-
tomy in asymptomatic patients with high-grade carotid
stenosis. To address some of these concerns, I would like to
address four questions.
Are there good data to support the efficacy of
carotid endarterectomy? It was not until the 1990s that a
large number of randomized trials were undertaken. These
demonstrated that carotid endarterectomy was beneficial
for patients with significant carotid artery stenosis and
transient ischemic attacks, and in addition the operation
also was beneficial to patients with significant carotid artery
stenosis who were without symptoms. Reports from the
NASCET [North American Symptomatic Carotid Endar-
terectomy Trial],5 the VA [Veterans Administration] Co-
operative Trial,6 and the ACAS [Asymtomatic Carotid
Atherosclerosis Study]7 indicated the benefit of surgical
treatment of carotid artery disease, but there were numer-
ous concerns that the operation was being overutilized.
Others were concerned that the results reported in these
trials could not be reproduced in practice. As reported in
the Dartmouth Atlas of Vascular Health Care,8 the number
of carotid endarterectomy procedures performed between
1983 and 1996 showed a marked increase after the publi-
cation of these trials. Between 1995 and 1997 the number
of carotid endarterectomies done in the United States
doubled, from 62,000 to 144,000. The number of carotid
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endarterectomies done in Medicare recipients reached a
high of 144,000 in 1997. In addition, there was some
concern that the rate of carotid endarterectomy carried out
in Medicare recipients varied considerably in various re-
gions of the United States, even after adjustment for differ-
ences in age, sex, race, and illness rates of the local popula-
tion. The rate of carotid endarterectomy ranged from 1 to
7.5 per thousand Medicare enrollees.
Numerous articles have appeared in the literature, with
such titles as “Carotid endarterectomy: Where do we draw
the line?,”9 “Carotid endarterectomy: Another wake-up
call,”10 and “Complication rates for carotid endarterec-
tomy: A call to action.”11 These articles imply that “we”
have overdone it and that results outside of trials are really
not that good.
Are results from trials achievable in practice? This is
an important question because unless carotid endarterec-
tomy can be done with acceptable morbidity and mortality
the benefits of this prophylactic operation cannot be
achieved. For example, the ACAS trial demonstrated an
annualized absolute risk reduction of 1.1% per year. This
was achieved with a perioperative stroke and death rate of
2.3%. However, others have argued that if the perioperative
stroke and death rate were 3% there would be no benefit to
carotid endarterectomy in this population. Consequently,
the question raised by some as to whether the efficacy
demonstrated in trials could be achieved in clinical practice
is a good question.12 Randomized trials generally exclude
high-risk patients to clearly define the benefit of the treat-
ment arm. For example, in the NASCET and ACAS trials,
exclusion criteria included previous carotid surgery, previ-
ous myocardial infarction, history of congestive heart fail-
ure, unstable angina, renal failure, respiratory failure, can-
cer, and combined carotid and coronary bypass surgery
patients. We need to consider whether the patients we see
in clinical practice, outside of trials, can have results similar
to those obtained in trials. A review of 25 studies reporting
30-day stroke and death rates suggested a 30-day mortality
of 1.3% in asymptomatic patients and 1.8% in symptomatic
patients. The combined stroke and death rate was 3% in
asymptomatic patients and 5.2% in symptomatic patients.13
A report from Olmstead County in Minnesota comparing
their operative results for carotid endarterectomy with the
NASCET trial showed similar favorable results.14 Exclu-
sion of high-risk subjects from these trials is of concern.
However, there are reports that show those similar favor-
able results in trial-eligible and trial-ineligible patients.15
Ricotta16 presented data at a recent national vascular meet-
ing that showed that operative results of carotid endarter-
ectomy were not statistically different in “normal risk” and
“high risk” patients, including myocardial infarction, tran-
scient ischemic attack, stroke, or death. Collectively these
data suggest that results of carotid endarterectomy in clin-
ical practice can be similar to those results obtained in
national trials.
Is there an association between volume and quality
outcomes? There is much discussion now about the rela-
tionship between operative volumes and clinical outcomes.
It has been suggested that high volume is associated with
better outcomes. Many questions arise here. Is it hospital
volume or is it surgeon volume? If there is a correlation
between volume and outcomes, why is that? Is it that
“practice makes perfect” or that there is a selective referral
to those hospitals or those physicians known to get good
results? So hospitals and surgeons with higher volume have
better systems in their institutions, resulting in better out-
comes?
A recent study addresses the correlation between hos-
pital volume and various surgical procedures and surgical
mortality.17 The report shows that surgical mortality de-
creases as hospital volume increases for 14 different surgical
procedures. However, the impact of volume varied consid-
erably among the different operative procedures. For exam-
ple, the difference between surgical mortality for pancreatic
resection when comparing high-volume hospitals with low-
volume hospitals was considerable, 3.8% versus 16.3%. For
carotid endarterectomy the difference in surgical mortality
between high-volume hospitals and low-volume hospitals
was 1.5% versus 1.7%. The conclusion of this report was
that Medicare patients undergoing certain operative inter-
ventions could significantly reduce their risk for operative
death by selecting a high-volume hospital.
Data from the Dartmouth Atlas8 show that there is a
difference in 30-day mortality for carotid endarterectomy
when comparing low-volume, medium-volume, and high-
volume institutions. High-volume institutions had the low-
est 30-day mortality, with results comparable to those of
the major trial hospital, but what constituted low volume,
medium volume, and high volume was not defined. In the
same Dartmouth Atlas there are data showing the 30-day
mortality rates for surgeons based on the number of carotid
endarterectomy procedures done per year. For surgeons
who performed 3 or fewer carotid endarterectomies per
year, 30-day mortality was 2.8%, whereas for surgeons who
performed 43 or more procedures per year, operative mor-
tality was 1.4%. This report also showed that for carotid
endarterectomy, for institutions that did more than 40
procedures per year, adjusted mortality was 1.7%, and for
institutions that did more than 110 procedures per year,
adjusted mortality was 1.5%. A report by Ruby et al18 also
shows a difference in combined stroke and death rates when
comparing surgeons who did 1 or less carotid endarterec-
tomy procedures per year with surgeons who did more than
10 procedures.
Most of these studies demonstrate a positive correla-
tion between volume and favorable outcomes, but there is
a large amount of variation in these reports. The variation is
probably related to what we mean by high and low volume.
There is institutional variability; there is variability in re-
sults, depending on the procedure; and also there is vari-
ability in results when comparing surgeons. The question
still is, If higher volume does equal better outcome, why is
that? It could be that practice makes perfect. The more you
do, the better you as a surgeon get. The more a hospital
does a particular operation, the better the hospital gets. It
could be that these better results have something to do with
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the processes of care. That is, higher volume surgeons or
higher volume hospitals have a better system worked out
for doing these procedures. It could be that the implemen-
tation of specific actions or treatment plans makes the
difference.
These issues remain unresolved, but some providers
have already begun to make reimbursement decisions based
on these correlations. For example, Leapfrog represents a
coalition of private and public purchasers of health insur-
ance. Leapfrog is composed of more than 100 Fortune 500
companies that purchase health care and are now insisting
on stringent safety standards.19 Because the Leapfrog
group purchases more than $53 billion worth of health care
each year, they are starting to impose certain requirements
on institutions who care for their employees, which include
measures to ensure patient safety and reduce the cost of
care. These initiatives include a computerized physician
order entry system, evidence-based hospital referrals, and
intensive care units staffed with credentialed physicians. In
my state of Massachusetts, regulatory agencies have asked
hospitals to report to insurance providers whether they
meet Leapfrog standards.
The Leapfrog group is advocating standards for evi-
dence-based hospital referrals, and in this list of standards
are hospital volume characteristics, which include mini-
mum volume characteristics, as follows: coronary artery
bypass surgery, 500 procedures per year; coronary angio-
plasty, 400 procedures per year; abdominal aortic aneurysm
repair, 30 procedures per year; esophageal cancer surgery, 7
procedures per year; and carotid endarterectomy, 100 pro-
cedures per year. They do suggest that in geographic areas
where scientifically rigorous risk-adjusted hospital outcome
comparisons are publicly reported, favorable risk-adjusted
outcomes will replace the favorable volume characteristics.
What are the implications of the Leapfrog initiative
in New England? According to Leapfrog, there is a re-
quirement of 100 carotid endarterectomies in an institu-
tion for it to be a favorable environment for their insured
individuals. To gather information about operative volume,
I asked various associations in each of the six New England
states for data on the number of carotid endarterectomy
procedures per hospitals in 2000 and 2001. The associa-
tions were CHIME [College of Healthcare Information
Management Executives] Incorporated of the Connecticut
Hospital Association, the Massachusetts Health Data Con-
sortium, the Maine Health Data Association, the New
Hampshire Hospital Association, the Vermont VAHHS
[Veterans Affairs Department of Health and Human Ser-
vices], and the Hospital Association of Rhode Island. The
Figure shows the number of carotid endarterectomies done
in each of 128 hospitals in the six New England states. You
will see that there are only 13 hospitals in New England that
perform 100 or more carotid endarterectomies per year.
The Table shows how many hospitals in New England
would qualify if the number of carotid endarterectomies
per year were reduced to other levels. It is clear from this
table that if 100 carotid endarterectomies per year were
required, only 10% of the hospitals in New England would
qualify. If that number were reduced to 50 procedures per
year, then 39% of the hospitals in New England would
qualify.
The potential problems to patients and physicians in
New England are obvious. Using volume as a surrogate for
Fig 1. Number of carotid endarterectomies performed per year in 128 hospitals in New England.
Number of hospitals that would qualify at various
volumes of carotid endarterectomy procedures performed
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quality, hospitals and surgeons will be required to increase
their volume of carotid endarterectomy procedures. Where
are they going to find this volume? If one assumes that all
patients with symptomatic carotid stenosis are currently
undergoing appropriate operative intervention, then the
only place for growth in volume is in patients who have
asymptomatic carotid stenosis. The temptation may be
great to lower our standards and to operate on less than
optimal candidates and to perhaps operate on carotid ste-
noses below the levels suggested by ACAS.
The Leapfrog criteria would also have an adverse effect
on manpower distribution in New England. A young sur-
geon who is looking for a place to practice will be quite
leery of practicing in a community whose surgical volume is
less than Leapfrog requirements. In addition, there is the
potential for problems with access to health care by our
patients. If carotid endarterectomy can only be done in
certain hospitals, our patients will be forced to travel,
perhaps a considerable distance, for this type of care. It
should also be mentioned that data from the National VA
Surgical Quality Improvement Program show no correla-
tion between volume and quality outcome.20
The volume considerations are masking the real issue
that we need to focus on. Although there is a correlation
between volume and quality of care, this correlation does
not establish a cause-effect relationship. The more impor-
tant questions are how one interprets the correlation and
what decisions one makes. There are examples of high
volume with poor results and low volume with good re-
sults. Also, where does one draw the line? There are numer-
ous examples of good quality results with less than 100
carotid endarterectomies per year.
Other questions need to be answered about this vol-
ume outcome relationship.21 Does this relationship dimin-
ish over time? Is there a threshold effect beyond which no
more improvement is made above a certain volume, or is
there the possibility of worsening results above a certain
volume? Is there a learning curve, and what is the shape of
this learning curve? Is the learning curve different for
experienced or new surgeons? How important is cumula-
tive lifetime volume? Is there a difference in outcomes when
comparing an older surgeon who has been practicing for
many years but whose volume is less than that suggested by
Leapfrog when compared with a young surgeon in a high-
volume practice almost immediately? Finally, does experi-
ence with similar procedures contribute to a favorable
outcome? For example, perhaps we are looking at the
wrong thing when we look at a specific operation, and
rather we should be looking at a cluster of operative proce-
dures that have great similarity. To quote John Daly, “Pro-
vider volume itself is not the equivalent of Healthcare.
Rather, it serves as a proxy for quality.”21
Can we improve our results? Are there things we can
do to improve carotid endarterectomy? In my opinion,
there are a number of considerations that are important.
We need to be sure that our indication for the procedure is
appropriate. NASCET and ACAS have clearly defined
those patients who are likely to benefit from carotid endar-
terectomy. We must be careful not to extend the indica-
tions into areas that have not been shown to be beneficial.
Risk assessment of our patients is essential. Patients at
higher risk for operative intervention than was present in
national randomized trials can have good results, but we
must be attentive to the careful preoperative evaluation of
such patients to minimize operative morbidity and mortal-
ity. I believe that accepted performance measurements for
carotid endarterectomy have been defined.
Perioperative transient ischemic attack, stroke, myocar-
dial infarction, local nerve injury, and death are clearly
defined and measurable. We must all track our patients and
know our results in all of these important areas.
I believe that we need to set benchmark standards for
results with various operations, especially with carotid end-
arterectomy. It has been clearly demonstrated that the
perioperative morbidity and mortality that were achieved in
national trials can be achieved in individual practice, and we
must insist that these benchmarking standards be adhered
to at our own institutions. We must be open to the concept
of system change. There are some systematic issues in our
institutions and in our practice that can make a difference.
For example, marking the operative site, something that
many of us did not enthusiastically embrace, has been
shown to be very beneficial in reducing mistakes. There are
numerous other system changes that we need to be aware
of. It could be that those institutions that have higher
volumes with good results and those institutions with lower
volumes with good results have achieved these results not
only because of the skill of the surgeon and the appropriate
selection of the patient but also because there are institu-
tional systems in place to ensure good results.
Finally, I believe that the use of protocols can be very
helpful. If the community of surgeons can agree on certain
issues regarding clinical care, then perhaps protocols should
be established to ensure that all surgeons adhere to the
protocol. For example, it is clearly shown that preoperative
anti-platelet therapy reduces perioperative mortality and
stroke, that the use of intraoperative heparin during carotid
endarterectomy is beneficial, and, finally, patch closure of
the endarterectomized segment ensures less recurrent ca-
rotid stenosis.22 If all the surgeons practicing in an institu-
tion adhere to protocols, perhaps results would improve
and perhaps lower volume institutions and surgeons could
get equally good results.
In summary, are there good data supporting carotid
endarterectomy? The answer is, unequivocally, yes. Are
results from trials achievable in clinical practice? The answer
is, unquestionably, yes. Is there an association between
volume and quality outcomes? Yes, but the question re-
mains, what does it mean? Although high-volume institu-
tions do get good results, there are also examples of low-
volume institutions also getting good results. Finally, can
we improve our results with carotid endarterectomy? The
answer is an unqualified yes. I believe that monitoring your
own personal results very closely, paying attention to pub-
lished reports of ways to improve operative results, picking
the right operation for the right patient and careful atten-
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tion to preoperative preparation and postoperative care can
only help to improve our collective results with carotid
endarterectomy.
I have focused on carotid endarterectomy because of
the current discussion as to the relative merits of this
operation, which I believe are unfounded. However, I am
convinced that the suggestions I have made to ensure
quality care of patients with carotid artery disease can be
transferred to any type of practice. Simply stated, I think we
need to understand and appreciate the excellent informa-
tion we have about the merits of carotid endarterectomy.
Trying to understand the reasons for better results in
high-volume hospitals, rather than focusing merely on vol-
ume, is very important. Adhering to established clinical
protocols, close monitoring of personal results, and de-
manding accepted benchmark results are essential. As long
as we are open minded about new treatment modalities and
if we adhere to the principle of evidence-based medicine,
practicing vascular surgeons will enjoy an excellent reputa-
tion and will enjoy the respect of the patients they are
privileged to care for.
I have enjoyed the honor and privilege of serving as the
29th President of the New England Society of Vascular
Surgery. I look forward to our Society’s continued growth.
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